Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Zhonghua Yi Xue Za Zhi|December 24, 2013
[Use of rebiopsy for clinically diagnosed metastatic lesion in patients with breast cancer]Qing Qu, Cheng Xu, Xiao-song Chen, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 16, 2007
[Stereotactic biopsy for non-palpable breast lesions: evaluation and choice of minimal invasive and excisional biopsy]Guang-yu Liu, Can-ming Chen, Zhen Hu, et al.
Cell Biochemistry and Biophysics|November 28, 2014
Prognostic factors of survival in pathologic incomplete response patients with locally advanced breast cancer after neoadjuvant chemotherapyOu Huang, Min Jiang, Xiao-song Chen, et al.
Frontiers in Oncology|February 11, 2020
A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant MetastasisZheng Wang, Hui Wang, Xi Sun, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 20, 2007
[Surgical management of early breast cancer]Gen-hong Di, Jiong Wu, Ke-da Yu, et al.
Annals of Surgical Oncology|June 15, 2007
Development and trends of surgical modalities for breast cancer in China: a review of 16-year dataKe-Da Yu, Gen-Hong Di, Jiong Wu, et al.
Molecular and Clinical Oncology|October 4, 2014
Long-term outcomes following adjuvant endocrine therapy in breast cancer patients with a positive-to-negative change of hormone receptor status following neoadjuvant chemotherapyJia Yi Wu, Wei Guo Chen, Xiao Song Chen, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 1, 2006
[Value of magnetic resonance imaging in diagnosing breast lesions which need biopsy]Hong Ling, Ya-jia Gu, Xiao-hong Wang, et al.
Annals of Surgical Oncology|December 7, 2018
The Role of the Neo-Bioscore Staging System in Guiding the Optimal Strategies for Regional Nodal Irradiation Following Neoadjuvant Treatment in Breast Cancer Patients with cN1 and ypN0-1Lu Cao, Cheng Xu, Youlia M Kirova, et al.
Asian Journal of Surgery|August 20, 2003
Addition of adjuvant tamoxifen to cyclophosphamide, methotrexate and 5-fluorouracil for premenopausal women with oestrogen receptor-positive breast cancerHe-Cheng Li, Xian-Feng Wen, Yi-Feng Hou, et al.
Pageof 6